← Back to Clinical Trials
Recruiting NCT04981730

NCT04981730 The Development and Evaluation of a Web-based Childbirth and Parenting Intervention Program

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04981730
Status Recruiting
Phase
Sponsor Taipei Medical University
Condition Parenting
Study Type INTERVENTIONAL
Enrollment 600 participants
Start Date 2023-12-14
Primary Completion 2025-10-14

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Web-based intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 600 participants in total. It began in 2023-12-14 with a primary completion date of 2025-10-14.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Background: The transition to parenthood is stressful for first-time mothers and fathers and links to adverse health outcomes. Despite Internet use's popularity, an effective web-based, individually-tailored intervention to enhance parental self-efficacy and infant health for first-time parents remains lacking. Objectives: This study aims to develop and evaluate the effectiveness of a web-based, individually-tailored childbirth and parenting intervention program on parenting self-efficacy and infant health outcomes. The feasibility and acceptability of a theory-driven intervention will be examined in first-time mothers and fathers. Methods: A two-arm, single-blind randomized controlled trial will be conducted to investigate the effects of web-based intervention in the first-time mother and father. Participants will be randomly allocated to a web-based intervention or a control condition. A repeated measurement will be performed. Anticipatory results: The efficacy of a theory-driven web-based, individually tailored intervention program will provide a valuable contribution to perinatal health care for first-time mothers and fathers.

Eligibility Criteria

Inclusion Criteria: for this study are first-time mothers and fathers who are 1. 20 years old and above; 2. primipara with a singleton pregnancy at second and third-trimester gestation; 3. able to read and write in Mandarin; 4. the husband or support partner will be willing to attend the intervention program; 5. able to access and use the Internet by computer and/or smartphone daily. Exclusion Criteria: are the first-time mothers and fathers who have 1. chronic diseases; 2. obstetric complications; 3. an abnormal fetal screening; 4. unable or unwilling to comply with the requirements of the research protocol; 5. women and their partners did not have time for the web-based intervention program; 6. participation on any other interventional study.

Contact & Investigator

Central Contact

Shu-Yu Kuo

✉ sykuo@tmu.edu.tw

📞 +886-2-2736-1661

Principal Investigator

Shu-Yu Kuo

PRINCIPAL INVESTIGATOR

Taipei Medical University

Frequently Asked Questions

Who can join the NCT04981730 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 60 Years, studying Parenting. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04981730 currently recruiting?

Yes, NCT04981730 is actively recruiting participants. Contact the research team at sykuo@tmu.edu.tw for enrollment information.

Where is the NCT04981730 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT04981730 clinical trial?

NCT04981730 is sponsored by Taipei Medical University. The principal investigator is Shu-Yu Kuo at Taipei Medical University. The trial plans to enroll 600 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology